The coronavirus disease 2019 (COVID19) pandemic continues to represent a substantial
public health concern. It can rapidly progress to severe disease, with poor prognosis and a …

Several studies have proposed that the neutrophil–lymphocyte ratio (NLR) is one of the
various biomarkers that can be useful in assessing COVID-19 disease-related outcomes …

Introduction Coronavirus Disease 2019 is a primarily respiratory illness that can cause
thrombotic disorders. Elevation of D-dimer is a potential biomarker for poor prognosis in …

Background The neutrophil-to-lymphocyte ratio (NLR), an inflammatory marker, was
suggested to be predictive of severity and mortality in COVID-19 patients. Here, we …

In acute coronavirus disease 19 (COVID‐19) patients, effective clinical risk stratification has
important implications on treatment and therapeutic resource distribution. This article …

Coronavirus disease 2019 (COVID-19) is characterized by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) needing mechanical ventilation and intensive care …

It is not clear whether D-dimer can be an independent predictor of coronavirus disease 2019
(COVID-19) mortality, and the cut-off of D-dimer for clinical use remains to be determined …

Since December 2019, the SARS-CoV-2 (COVID-19) pandemic has transfixed the medical
world. COVID-19 symptoms vary from mild to severe and underlying chronic conditions such …

Background Although cases of respiratory bacterial infections associated with coronavirus
disease 2019 (COVID-19) have often been reported, their impact on the clinical course …

Objective Plasma D-dimer levels> 5000 ng/mL are encountered in a number of conditions
other than venous thromboembolism (VTE). Recent studies have used plasma D-dimer …